Analysts expect Picard Medical, Inc. to report revenue of 1.49 M for Q3 26, against a range of 1.44 M to 1.55 M. The most recent reported quarter, Q2 26, came in at 2.95 M, a 85.9% beat against the 1.59 M consensus.
| Metric | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 1.01 M | 1.15 M | 2.95 M | - | - | - | - | - | - | - | - | ||
| High Estimate | - | 1.13 M | 1.74 M | 1.55 M | 1.41 M | 1.22 M | 1.82 M | 1.53 M | 1.32 M | 1.28 M | 1.90 M | ||
| Low Estimate | - | 1.03 M | 1.44 M | 1.44 M | 1.18 M | 1.02 M | 1.61 M | 1.38 M | 1.16 M | 1.20 M | 1.65 M | ||
| Consensus Estimate | - | 1.08 M | 1.59 M | 1.49 M | 1.30 M | 1.12 M | 1.71 M | 1.45 M | 1.24 M | 1.24 M | 1.78 M |
Analysts expect Picard Medical, Inc. to report earnings per share of -1.59 for Q3 26, against a range of -1.70 to -1.48. The most recent reported quarter, Q2 26, came in at -3.05, a 116.3% miss against the -1.41 consensus.
| Metric | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -3.00 | -5.00 | -3.05 | - | - | - | - | - | - | - | - | ||
| High Estimate | - | -4.32 | -1.34 | -1.48 | -1.44 | -1.47 | -1.02 | -0.07 | -0.22 | 0.78 | 1.52 | ||
| Low Estimate | - | -5.20 | -1.48 | -1.70 | -1.68 | -1.61 | -1.10 | -0.09 | -0.26 | 0.72 | 1.42 | ||
| Consensus Estimate | - | -4.76 | -1.41 | -1.59 | -1.56 | -1.54 | -1.06 | -0.08 | -0.24 | 0.75 | 1.47 |